135 related articles for article (PubMed ID: 8366576)
41. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
42. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
[TBL] [Abstract][Full Text] [Related]
43. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
44. Cytogenetic profile of chronic myeloid leukemias.
Jacob RT; Gayathri K; Surath A; Rao DR
Indian J Cancer; 2002 Jun; 39(2):61-5. PubMed ID: 12789726
[TBL] [Abstract][Full Text] [Related]
45. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
46. [A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
Yoshizaki N; Kohda K; Nakazawa O; Ando M; Miyazaki S; Takahashi M; Muramatsu H; Terada S; Kure T; Niitsu Y
Rinsho Ketsueki; 1989 May; 30(5):691-6. PubMed ID: 2529382
[TBL] [Abstract][Full Text] [Related]
47. Intensive polychemotherapy experience in chronic myeloid leukaemia.
Centurioni R; Leoni P; Russo D; Brianzoni MF; Montillo M; Baccarani M; Tura S
Haematologica; 1989; 74(5):491-3. PubMed ID: 2511120
[TBL] [Abstract][Full Text] [Related]
48. [Two cases of unclassified chronic myeloproliferative disorders].
Hirano A; Takahashi I; Haruta Y; Nakamura T; Nakata H; Yorimitsu S; Sekito N; Kimura I
Rinsho Ketsueki; 1992 Apr; 33(4):525-31. PubMed ID: 1602619
[TBL] [Abstract][Full Text] [Related]
49. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
Takami A; Chuhjo T; Nakao S
Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
[No Abstract] [Full Text] [Related]
50. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
51. [CML with autoimmune thrombocytopenia observed in the course of IgG (kappa) type monoclonal gammopathy].
Nakase T; Matsuoka N; Iwasaki E; Ukyo S; Shirakawa S
Rinsho Ketsueki; 1992 May; 33(5):706-8. PubMed ID: 1630025
[TBL] [Abstract][Full Text] [Related]
52. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
53. [Hematologic abnormalities in a patient with chronic myelogenous leukemia with advanced myelofibrosis were improved by G-CSF].
Hiruma K; Saitoh H; Someya K; Kashimura M
Rinsho Ketsueki; 1994 Feb; 35(2):135-41. PubMed ID: 7511182
[TBL] [Abstract][Full Text] [Related]
54. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of cytogenetic analysis in chronic myeloid leukemia (with report of 155 cases).
Du QF; Liu XL; Song LL; Zhang S; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):905-7. PubMed ID: 12377614
[TBL] [Abstract][Full Text] [Related]
56. ["Lymphoid" blastic transformation in chronic myelogenous leukemia. Report of three cases (author's transl)].
Bauters F; Jouet JP; Huart JJ; Jude B; Toussaint B; Goudemand M
Sem Hop; 1982 Jan; 58(1):17-23. PubMed ID: 6275542
[TBL] [Abstract][Full Text] [Related]
57. [So-called Ph1-negative chronic myelogenous leukemia with a mosaic pattern of trisomy 8 and normal karyotypes--report of 2 cases].
Murase T; Nagai H; Wakita A; Fujiwara Y; Nakaide Y; Tanaka M; Ohkita T; Hotta T
Rinsho Ketsueki; 1989 Apr; 30(4):509-13. PubMed ID: 2769971
[TBL] [Abstract][Full Text] [Related]
58. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
59. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
[TBL] [Abstract][Full Text] [Related]
60. Effect of interferon-alpha on chromosome abnormalities in treated chronic myelogenous leukemia patients.
Tanaka H; Tanaka K; Oguma N; Ito K; Ito T; Kyo T; Dohy H; Kimura A
Cancer Genet Cytogenet; 2004 Sep; 153(2):133-43. PubMed ID: 15350303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
